Skip to main content

Table 1 Clinical data and main diagnosis of treatment of NRBC-positive (n = 67) and NRBC-negative (n = 316) patients

From: Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study

Parameter

NRBC-positive

NRBC-negative

P

Age, years

68 ± 2

66 ± 1

n.s.

Gender, male/female

55%/45%

59%/41%

n.s.

Intensive care treatment, days

8.7 ± 1.2

3.2 ± 0.2

< 0.001

Body mass index

27.8 ± 0.9

26.5 ± 0.3

n.s.

Mortality

50.7%

9.8%

< 0.001

APACHE II score points

21.5

14.9

< 0.001

SAPS II points

47.5

32.6

< 0.001

Acute coronary syndrome/AMI

16.4% (n = 11)

38.0% (n = 120)

< 0.001

Cardiac arrhythmia

10.4% (n = 7)

14.2% (n = 45)

n.s.

Cardiac insufficiency

11.9% (n = 8)

6.6% (n = 21)

n.s.

Pulmonary diseases

23.9% (n = 16)

8.9% (n = 28)

< 0.01

Gastrointestinal diseases

16.4% (n = 11)

7.9% (n = 25)

< 0.05

Cerebral diseases

6.0% (n = 4)

10.1% (n = 32)

n.s.

Toxication

4.5% (n = 3)

4.1% (n = 13)

n.s.

Metabolic diseases

1.5% (n = 1)

4.4% (n = 14)

n.s.

Other diagnosis

9.0% (n = 6)

5.7% (n = 18)

n.s.

  1. AMI, acute myocardial infarction; APACHE II, Acute Physiology and Chronic Health Evaluation II; NRBC, nucleated red blood cell; n.s., not significant; SAPS II, Simplified Acute Physiology Score II.